Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
JAZZ	JAZZ PHARMACEUTICALS PLC	$14.17B	0.70%	0.30%	-0.39%	-0.50%	1.62	2.04	88.00%	0.70%	-0.85%
EXEL	EXELIXIS INC	$12.11B	40.20%	30.50%	45.14%	46.40%	0.34	3.26	96.40%	35.10%	42.23%
PBYI	PUMA BIOTECHNOLOGY INC	$381.24M	20.40%	12.10%	25.77%	47.90%	0.50	2.38	74.50%	10.70%	15.08%
AUPH	AURINIA PHARMACEUTICALS INC	$1.96B	64.50%	47.60%	21.65%	25.00%	0.28	5.55	89.70%	100.00%	46.27%
ONC	BEONE MEDICINES LTD	$34.73B	12.10%	6.70%	11.16%	23.00%	0.80	3.64	88.30%	8.90%	13.11%
ANAB	ANAPTYSBIO INC	$1.99B	N/A	-3.60%	-4.01%	-2.40%	8.79	9.07	100.00%	-5.60%	-5.57%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.13B	735.00%	3.20%	14.87%	13.00%	29.13	2.12	85.90%	3.80%	12.92%
PTGX	PROTAGONIST THERAPEUTICS INC	$6.39B	-17.80%	-16.50%	-17.40%	-22.40%	0.06	17.76	100.00%	-154.90%	-155.78%
VCYT	VERACYTE INC	$3.23B	6.90%	6.30%	6.57%	42.50%	0.07	9.31	70.90%	16.20%	16.75%
RPRX	ROYALTY PHARMA PLC	$29.25B	8.50%	4.30%	6.03%	4.50%	0.99	2.66	100.00%	33.90%	47.67%
SPRO	SPERO THERAPEUTICS INC	$148.20M	22.50%	13.00%	14.71%	85.80%	0.17	7.59	100.00%	12.80%	13.22%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$4.51B	13.30%	9.90%	15.85%	25.20%	0.36	3.79	89.30%	9.70%	14.06%
CUE	CUE BIOPHARMA INC	$113.94M	-165.20%	-77.80%	-89.65%	-761.70%	0.60	2.74	100.00%	-96.90%	-93.73%
ASMB	ASSEMBLY BIOSCIENCES INC	$472.65M	-4.20%	-3.10%	-3.18%	-5.10%	0.19	6.65	N/A	N/A	N/A
ALNY	ALNYLAM PHARMACEUTICALS INC	$39.39B	98.30%	11.80%	23.01%	17.20%	3.77	3.13	80.80%	13.50%	20.29%
AGEN	AGENUS INC	$146.68M	N/A	0.00%	-57.28%	-318.60%	-1.86	0.41	99.10%	-0.10%	48.50%
REGN	REGENERON PHARMACEUTICALS INC	$74.95B	14.30%	11.10%	14.55%	15.20%	0.30	3.57	84.50%	29.60%	34.89%
KRYS	KRYSTAL BIOTECH INC	$9.01B	19.30%	17.60%	16.08%	27.50%	0.09	9.46	94.20%	53.90%	49.68%
LQDA	LIQUIDIA CORP	$3.73B	-209.30%	-25.30%	-23.29%	-24.60%	6.33	2.01	91.60%	-43.50%	-28.27%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.50B	-7.10%	-2.50%	0.03%	0.00%	1.72	4.18	98.90%	-6.70%	0.07%
CGEN	COMPUGEN LTD	$274.20M	55.70%	29.70%	26.42%	197.10%	0.52	6.56	87.30%	48.60%	48.65%
INCY	INCYTE CORP	$19.69B	29.20%	21.70%	30.37%	79.50%	0.31	3.68	92.50%	26.70%	33.13%
TBPH	THERAVANCE BIOPHARMA INC	$876.92M	43.80%	25.50%	31.49%	62.00%	0.63	13.14	100.00%	104.30%	126.38%
STTK	SHATTUCK LABS INC	$525.26M	-60.70%	-55.70%	-50.96%	-188.80%	0.07	22.07	100.00%	-4,987.40%	-4,987.40%
XLO	XILIO THERAPEUTICS INC	$44.76M	-311.80%	-26.60%	-35.60%	119.70%	3.39	2.58	100.00%	-80.10%	-80.05%
INVA	INNOVIVA INC	$1.69B	47.60%	32.40%	34.30%	58.30%	0.37	21.13	73.70%	119.90%	146.77%
SLGL	SOL-GEL TECHNOLOGIES LTD	$197.43M	-23.70%	-18.60%	-25.80%	-47.00%	0.31	4.37	100.00%	-31.60%	-31.60%
VCEL	VERICEL CORP	$1.71B	6.40%	4.60%	5.24%	5.50%	0.36	5.18	74.80%	7.30%	7.86%
ASND	ASCENDIS PHARMA A	$14.82B	-5,435.60%	35.80%	7.06%	7.60%	3.11	1.00	89.00%	57.30%	7.15%
ZVRA	ZEVRA THERAPEUTICS INC	$657.95M	81.30%	45.60%	60.94%	67.80%	0.35	4.89	86.10%	101.60%	115.40%
VRTX	VERTEX PHARMACEUTICALS INC	$109.09B	23.90%	17.20%	22.90%	31.70%	0.37	3.02	86.20%	35.50%	42.36%
NVO	NOVO NORDISK A S	$205.70B	66.40%	23.30%	46.60%	55.60%	1.75	0.79	81.80%	37.20%	47.49%
PRTA	PROTHENA CORP PUBLIC LTD CO	$561.75M	-49.90%	-42.30%	-33.63%	622.40%	0.12	10.43	100.00%	-260.90%	-184.21%
MGTX	MEIRAGTX HOLDINGS PLC	$799.80M	N/A	-53.30%	-83.70%	-65.60%	-43.19	0.75	94.00%	-140.30%	-125.33%
TARS	TARSUS PHARMACEUTICALS INC	$2.63B	-14.20%	-8.90%	-8.00%	-9.70%	0.67	3.74	93.50%	-9.00%	-6.54%
ARGX	ARGENX SE	$48.40B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$2.11B	4.90%	1.90%	0.91%	0.80%	1.11	4.63	62.90%	3.00%	1.12%
ENTA	ENANTA PHARMACEUTICALS INC	$445.16M	-78.60%	-23.20%	-22.46%	-23.10%	1.60	4.44	100.00%	-106.80%	-95.48%
LCTX	LINEAGE CELL THERAPEUTICS INC	$341.25M	-131.00%	-62.80%	-67.99%	-1,983.10%	1.55	5.20	99.00%	-436.50%	-472.75%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.65B	-1.40%	-0.60%	4.07%	3.70%	1.43	2.68	90.90%	-0.60%	2.91%
TVTX	TRAVERE THERAPEUTICS INC	$3.96B	-26.80%	-3.80%	-2.42%	-1.90%	4.62	3.13	98.60%	-4.00%	-1.94%
ORMP	ORAMED PHARMACEUTICALS INC	$165.42M	36.70%	33.70%	35.58%	55.80%	0.16	6.98	0.60%	3,202.50%	3,767.90%
HALO	HALOZYME THERAPEUTICS INC	$7.57B	92.70%	14.10%	20.65%	20.10%	50.73	4.66	83.60%	22.70%	34.73%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$107.08M	10.60%	8.40%	6.37%	36.60%	0.06	35.56	N/A	N/A	N/A
GERN	GERON CORP	$891.71M	-28.00%	-12.10%	-7.75%	-5.50%	1.33	6.78	97.30%	-34.30%	-18.21%
INSM	INSMED INC	$21.97B	-130.10%	-51.60%	-63.90%	-62.60%	1.95	4.47	81.80%	-144.40%	-133.71%
NRXP	NRX PHARMACEUTICALS INC	$101.85M	N/A	-283.50%	178.92%	110.80%	-1.81	0.31	58.80%	-2,336.50%	-2,281.71%
PHAR	PHARMING GROUP NV	$910.78M	4.70%	2.60%	5.31%	7.80%	0.82	2.63	88.10%	3.30%	5.42%
VRCA	VERRICA PHARMACEUTICALS INC	$137.26M	N/A	-42.30%	-33.05%	-46.20%	0.91	2.59	90.30%	-50.30%	-28.51%
FTRE	FORTREA HOLDINGS INC	$1.46B	-79.10%	-16.30%	-20.47%	-28.40%	4.10	0.95	18.90%	-16.50%	-13.26%
NUVB	NUVATION BIO INC	$1.67B	-44.10%	-23.80%	-23.68%	-21.70%	0.91	7.44	90.80%	-102.10%	-87.84%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.45B	4.40%	3.40%	5.24%	7.10%	0.38	5.81	76.50%	8.30%	12.60%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.25B	-44.70%	-14.80%	-12.40%	-14.70%	1.63	5.91	29.30%	-51.10%	-40.60%
TECH	BIO-TECHNE CORP	$7.57B	5.50%	4.30%	6.49%	12.30%	0.22	4.49	65.00%	9.00%	12.86%
OMER	OMEROS CORP	$1.02B	N/A	-1.40%	-0.93%	-0.40%	-3.69	2.76	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$7.08B	-25.00%	-22.30%	-19.59%	-26.80%	0.08	10.81	100.00%	-612.00%	-611.26%
FENC	FENNEC PHARMACEUTICALS INC	$238.91M	-220.90%	-18.50%	-12.58%	-23.60%	0.99	6.37	91.60%	-21.80%	-16.92%
ADMA	ADMA BIOLOGICS INC	$1.89B	39.00%	27.40%	36.10%	39.40%	0.70	6.95	61.30%	32.40%	41.89%
ABUS	ARBUTUS BIOPHARMA CORP	$848.37M	-42.40%	-32.50%	-37.70%	-47.50%	0.24	15.73	100.00%	-237.90%	-237.19%
LGND	LIGAND PHARMACEUTICALS INC	$4.44B	16.20%	11.10%	12.77%	15.60%	0.54	21.28	95.30%	55.90%	69.40%
PTCT	PTC THERAPEUTICS INC	$6.11B	N/A	-6.80%	-3.52%	-6.70%	-16.90	2.44	92.50%	-22.60%	-8.28%
DTIL	PRECISION BIOSCIENCES INC	$198.42M	-79.60%	-34.80%	-31.01%	-113.80%	0.89	14.02	100.00%	-96.70%	-93.67%
CBIO	CRESCENT BIOPHARMA INC	$517.25M	-100.90%	-88.20%	-85.98%	1,853.70%	0.08	13.78	100.00%	-1,494.60%	-1,466.29%
NAMS	NEWAMSTERDAM PHARMA CO NV	$4.53B	-29.80%	-27.40%	-31.98%	-106.30%	0.10	9.76	100.00%	-942.80%	-942.76%
UTHR	UNITED THERAPEUTICS CORP	$23.98B	19.20%	17.20%	26.58%	30.40%	0.14	4.79	86.60%	40.60%	51.27%
LEGN	LEGEND BIOTECH CORP	$5.20B	-29.20%	-17.60%	-23.80%	-36.80%	0.73	1.96	60.30%	-28.80%	-25.39%
PLYX	POLARYX THERAPEUTICS INC	$173.28M	-193.70%	-176.70%	-196.82%	3,689.90%	0.13	8.55	N/A	N/A	N/A
ALEC	ALECTOR INC	$233.15M	-295.20%	-40.90%	-62.94%	-60.60%	22.11	5.25	100.00%	-680.80%	-679.92%
KZIA	KAZIA THERAPEUTICS LTD	$818.46M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
URGN	UROGEN PHARMA LTD	$1.43B	N/A	-62.80%	-60.50%	-59.20%	-3.04	4.69	89.90%	-94.80%	-87.44%
ARDX	ARDELYX INC	$1.67B	-38.10%	-11.90%	-9.22%	-6.60%	2.40	3.49	92.50%	-13.60%	-8.52%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$236.42M	-185.10%	-65.90%	-52.54%	-87.70%	0.96	6.45	99.40%	-158.20%	-153.97%
ELVN	ENLIVEN THERAPEUTICS INC	$2.48B	-21.00%	-20.40%	-21.79%	-27.70%	0.03	40.32	N/A	N/A	N/A
OVID	OVID THERAPEUTICS INC	$369.25M	-24.00%	-18.60%	-12.21%	-22.80%	0.16	8.97	100.00%	-240.10%	-240.13%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.79B	17.20%	12.00%	20.07%	48.50%	0.40	3.58	76.50%	16.20%	23.54%
ANL	ADLAI NORTYE LTD	$530.67M	-414.00%	-67.20%	472.51%	547.00%	-5.14	0.65	100.00%	-710.60%	-679.94%
MANE	VERADERMICS INC	$3.96B	N/A	-80.10%	-58.11%	-139.60%	-0.08	16.66	N/A	N/A	N/A
ADAG	ADAGENE INC	$174.85M	-41.00%	-21.00%	-32.86%	113.30%	0.75	3.07	100.00%	-229.60%	-227.41%
NAGE	NIAGEN BIOSCIENCE INC	$332.12M	25.40%	18.20%	21.52%	118.30%	0.39	4.61	64.30%	14.30%	15.10%
SNSE	SENSEI BIOTHERAPEUTICS INC	$31.36M	-83.60%	-70.00%	-112.88%	-119.60%	0.23	5.06	N/A	N/A	N/A
SEPN	SEPTERNA INC	$1.07B	-12.60%	-9.50%	-9.60%	-17.50%	0.56	4.73	100.00%	-106.40%	-106.35%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$2.21B	-24.30%	-9.90%	-9.05%	-8.60%	1.30	3.35	75.30%	-16.80%	-12.84%
ALLO	ALLOGENE THERAPEUTICS INC	$555.81M	-57.10%	-41.60%	-49.51%	-51.20%	0.42	7.93	N/A	N/A	N/A
AKTS	AKTIS ONCOLOGY INC	$993.30M	N/A	-21.60%	-27.28%	-26.20%	-0.53	7.37	100.00%	-980.90%	-980.93%
CCCC	C4 THERAPEUTICS INC	$287.86M	-53.80%	-33.90%	-32.17%	-39.60%	0.40	7.81	100.00%	-292.10%	-291.74%
RLYB	RALLYBIO CORP	$76.07M	-16.20%	-15.00%	-15.47%	-26.80%	0.07	14.51	100.00%	-1,046.40%	-1,046.39%
JANX	JANUX THERAPEUTICS INC	$864.45M	-11.80%	-11.20%	-11.81%	-11.90%	0.09	17.01	100.00%	-833.60%	-833.60%
MESO	MESOBLAST LTD	$1.90B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
IFRX	INFLARX NV	$186.52M	-94.90%	-70.70%	-114.27%	-126.30%	0.33	4.16	-24,646.30%	-146,303.90%	-146,091.95%
GYRE	GYRE THERAPEUTICS INC	$724.32M	5.50%	3.30%	6.48%	9.80%	0.23	5.60	95.40%	4.30%	8.22%
ALMS	ALUMIS INC	$3.01B	-72.60%	-54.90%	-74.39%	-96.50%	0.37	4.34	100.00%	-1,011.70%	-1,047.34%
SLN	SILENCE THERAPEUTICS PLC	$328.90M	N/A	-53.70%	-71.69%	-94.10%	-1.33	9.83	79.50%	-8,943.90%	-8,942.55%
IONS	IONIS PHARMACEUTICALS INC	$12.47B	-58.60%	-10.10%	-8.60%	-6.10%	6.02	4.10	98.40%	-30.90%	-22.21%
KLRS	KALARIS THERAPEUTICS INC	$116.48M	-73.10%	-43.60%	-37.49%	-426.00%	0.55	12.23	N/A	N/A	N/A
OABI	OMNIAB INC	$240.65M	-20.30%	-18.10%	-19.73%	-78.00%	0.12	4.80	98.90%	-187.60%	-190.93%
PLX	PROTALIX BIOTHERAPEUTICS INC	$156.31M	-13.50%	-8.30%	-7.91%	-9.80%	0.71	2.51	48.80%	-12.50%	-8.37%
NRXS	NEURAXIS INC	$91.74M	-338.00%	-154.50%	-213.92%	690.70%	0.88	2.05	84.20%	-241.40%	-216.47%
SPTX	SEAPORT THERAPEUTICS INC	N/A	N/A	N/A	-31.37%	N/A	-0.18	17.46	N/A	N/A	N/A
PRLD	PRELUDE THERAPEUTICS INC	$306.19M	-130.00%	-80.90%	-112.65%	-138.00%	1.06	1.99	100.00%	-819.60%	-819.59%
ACIU	AC IMMUNE SA	$290.98M	-124.00%	-40.50%	-146.14%	1,976.70%	3.36	0.87	100.00%	-1,788.80%	-1,783.31%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 27, which is 2 points higher than the biotech industry average of 25.

JAZZ passed 9 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 129.44% over the past year, overperforming other biotech stocks by 132 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $237.67, an upside of 5.26% from Jazz Pharmaceuticals's current stock price of $225.79.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Jazz Pharmaceuticals, 58.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 8.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: B.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 52, which is 27 points higher than the biotech industry average of 25.

EXEL passed 17 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 31.95% over the past year, overperforming other biotech stocks by 34 percentage points.

Exelixis has an average 1 year price target of $48.00, a downside of -0.33% from Exelixis's current stock price of $48.16.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 14.29% have issued a Strong Buy rating, 14.29% have issued a Buy, 71.43% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 56, which is 31 points higher than the biotech industry average of 25.

PBYI passed 18 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 143.97% over the past year, overperforming other biotech stocks by 146 percentage points.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 18.27%, which is 14 percentage points higher than the biotech industry average of 4.3%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.11%, which is 2 percentage points higher than the biotech industry average of 4.3%.

Oramed Pharmaceuticals's dividend payout ratio of 16.3% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.77%, which is -2 percentage points lower than the biotech industry average of 4.3%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 43.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.17% in the last day, and up 2.15% over the last week. Traws Pharma was the among the top gainers in the biotechnology industry, gaining 28.24% yesterday.

Traws Pharma shares are trading higher after the company announced plans to advance potential clinical candidates for the treatment of hantavirus infections.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Rigel Pharmaceuticals has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Rigel Pharmaceuticals's stock has gained 37.78% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 65.01% in the past year. It has overperformed other stocks in the biotech industry by 67 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -9.09% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

65.08% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 61.11% over the next year.

3.09% of biotech stocks have a Zen Rating of A (Strong Buy), 3.75% of biotech stocks are rated B (Buy), 47.46% are rated C (Hold), 34.44% are rated D (Sell), and 11.26% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.13x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Exelixis (NASDAQ:EXEL)

3. Puma Biotechnology (NASDAQ:PBYI)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Rigel Pharmaceuticals (NASDAQ:RIGL)

2. Incyte (NASDAQ:INCY)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.